{
"NDC": {
"NDCCode": "75834-295-01",
"PackageDescription": "100 mL in 1 BOTTLE (75834-295-01) ",
"NDC11Code": "75834-0295-01",
"ProductNDC": "75834-295",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Erythromycin Ethylsuccinate",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Erythromycin Ethylsuccinate",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20230201",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA216212",
"LabelerName": "Nivagen Pharmaceuticals, Inc.",
"SubstanceName": "ERYTHROMYCIN ETHYLSUCCINATE",
"StrengthNumber": "200",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-01-18",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20230201",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}